How I treat enteropathy-associated T-cell lymphoma by Antonio Di Sabatino, Federico Biagi, Paolo G. Gobbi, and Gino R. Corazza Blood Volume 119(11):2458-2468.

Slides:



Advertisements
Similar presentations
Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):
Advertisements

Granular Histiocytosis of Pelvic Lymph Nodes following Total Hip Arthroplasty. The Presence of Wear Debris, Cytokine Production, and Immunologically Activated.
Blockade of osteopontin reduces alloreactive CD8 + T cell– mediated graft-versus-host disease by Fang Zhao, Yi Zhang, Hao Wang, Min Jin, Shan He, Yufang.
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases by Porcia T. Bradford, Susan S. Devesa, William F. Anderson,
How I treat HHV8/KSHV-related diseases in posttransplant patients by Giovanni Riva, Mario Luppi, Patrizia Barozzi, Fabio Forghieri, and Leonardo Potenza.
High Cure Rates of the Short-Term GITIL Chemotherapy Programme for Adult Patients with Burkitt Lymphoma by Jacopo Mariotti, Anna Guidetti, Michele Magni,
EBV-positive diffuse large B-cell lymphoma of the elderly by Chi Young Ok, Thomas G. Papathomas, L. Jeffrey Medeiros, and Ken H. Young Blood Volume 122(3):
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8 + T-cell killing by Patrizia Leone, Simona.
How I treat prolymphocytic leukemia
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells by Jonathan M. Irish,
Compliant with neg bx (6) Compliant with pos bx (3)
Celiac Disease: An Immunological Jigsaw
A Single Center Experience of Treatment of
Coeliac Disease at ABCD
Triple-Negative Breast Cancer
The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.
The beauty of TLR agonists for CTCL
Interleukin-12 Therapy of Cutaneous T-Cell Lymphoma Induces Lesion Regression and Cytotoxic T-Cell Responses by Alain H. Rook, Gary S. Wood, Elisa K. Yoo,
GVHD-associated immunodeficiency: soil or seed?
Do HSCs divide asymmetrically?
by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E
NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case.
Carlo Catassi, Italo Bearzi, Geoffrey K.T. Holmes  Gastroenterology 
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma.
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis by Paolo Prandoni,
Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients by Monia Ouederni, Quentin.
by James O. Armitage, and Dan L. Longo
by David W. Bahler, John A. Miklos, and Steven H. Swerdlow
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
CD3−CD56+ Non-Hodgkin's Lymphomas With an Aggressive Behavior Related to Multidrug Resistance by Bernard Drénou, Thierry Lamy, Laurence Amiot, Olivier.
How I treat elderly patients with myeloma
by Qin Huang Blood Volume 122(1):6-6 July 4, 2013
by Petri Salven, Lasse Teerenhovi, and Heikki Joensuu
European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals.
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group by Yok-Lam Kwong, Won Seog Kim, Soon Thye.
IL-6 and MYC collaborate in plasma cell tumor formation in mice
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases by Massimo Federico, Umberto Vitolo, Pier Luigi Zinzani,
Stage C or not stage C…? by Claire Dearden Blood
Primary testicular lymphoma
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma.
Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma by Hannes Kaufmann, Markus Raderer, Stefan Wöhrer,
Lymphoma spread? Target CD47-SIRPα!
How I treat refractory CLL
Primary chest wall lymphoma with no history of tuberculous pyothorax: Diagnosis and treatment  Abbas Tabatabai, MD, Mozaffar Hashemi, MD, Mojtaba Ahmadinejad,
Spreading and focusing of gluten epitopes in celiac disease
Anergy: the CLL cell limbo
by Oleg I. Krijanovski, Geoffrey R. Hill, Kenneth R
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis by.
Treatment of 7 patients with relapsed/refractory NK/T-cell lymphomas treated with pembrolizumab. Treatment of 7 patients with relapsed/refractory NK/T-cell.
Splenic Hypofunction and the Spectrum of Autoimmune and Malignant Complications in Celiac Disease  Antonio Di Sabatino, Maria Manuela Rosado, Paolo Cazzola,
N. Scott Reading, Stephen D. Jenson, Jeffrey K. Smith, Megan S
Rachele Ciccocioppo, MD, Alessandra Gallia, MD, Maria A
An Elderly Woman With Stridor
Figure 1 Evolution of blood cell counts during 18-month treatment and follow-up (A) Mean white blood cell count, (B) mean lymphocyte count, (C) mean eosinophil.
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL by Monika Pilichowska, Stefania Pittaluga,
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis by Samuel Yamshon,
Histological and immunohistochemical evaluation of primary central nervous system lymphoma. Histological and immunohistochemical evaluation of primary.
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Anti-CD20-IL-21 fusokine: the tail wags the dog
An algorithmic approach to FL
Acanthosis nigricans in a patient with sarcoma of unknown origin
by Lapo Alinari, and Kristie A. Blum
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
Optimizing therapy for nodal marginal zone lymphoma
How I treat T-cell acute lymphoblastic leukemia in adults
Balancing bleeding in brain metastases
Cold agglutinin disease
Presentation transcript:

How I treat enteropathy-associated T-cell lymphoma by Antonio Di Sabatino, Federico Biagi, Paolo G. Gobbi, and Gino R. Corazza Blood Volume 119(11): March 15, 2012 ©2012 by American Society of Hematology

Schematic representation of IL-15 lymphomagenic action leading to the emergence of EATL in CD. In active CD mucosa, IL-15, mainly produced by epithelial cells and dendritic cells (DCs), which present tissue transglutaminase (tTG)–deamidated gluten peptides... Antonio Di Sabatino et al. Blood 2012;119: ©2012 by American Society of Hematology

Proposed diagnostic algorithm in EATL. The recurrence of celiac symptoms in a patient with CD under GFD, or the persistence of celiac symptoms in a recently diagnosed CD patient despite a GFD followed for more than 12 months, should raise the suspicion of R... Antonio Di Sabatino et al. Blood 2012;119: ©2012 by American Society of Hematology

Features of EATL at PET scan. Antonio Di Sabatino et al. Blood 2012;119: ©2012 by American Society of Hematology

Histologic features of EATL. Medium-sized to large tumor cells with hyperchromatic nuclei, prominent nucleoli, and moderate to abundant, pale-staining cytoplasm, intermingled with eosinophils, are evident in the small bowel tissue specimen of a patient with... Antonio Di Sabatino et al. Blood 2012;119: ©2012 by American Society of Hematology

Main therapeutic options (white areas), 5-year survival, and IEL or infiltrating lymphoma cell immunophenotype (black areas), along the lymphomagenic process leading from uncomplicated CD to EATL through RCD. Unlike RCD1 (RCD1), which can benefit from stero... Antonio Di Sabatino et al. Blood 2012;119: ©2012 by American Society of Hematology